TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells
Katia Schoelera b, Andreas Aufschnaitera b, Simon Messnera b, Emmanuel Derudderc d, Sebastian Herzoga b, Andreas Villungera b e f g h, Klaus Rajewskyi, Verena Labia b✉
- aDivision of Developmental Immunology Biocenter, Medical University of Innsbruck Austria
- bDivision of Developmental Immunology, Biocenter, Medical University of Innsbruck, Austria
- cInstitute for Biomedical Aging Research University of Innsbruck Austria
- dInstitute for Biomedical Aging Research, University of Innsbruck, Austria
- eCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Vienna Austria
- fLudwig Boltzmann Institute for Rare and Undiagnosed Diseases Vienna Austria
- gCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
- hLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria
- iMax Delbrück Center for Molecular Medicine in the Helmholtz Association Berlin‐Buch Germany
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
Upon activation by antigen, B cells form germinal centres where they clonally expand and introduce affinity-enhancing mutations into their B-cell receptor genes. Somatic mutagenesis and class switch recombination (CSR) in germinal centre B cells are initiated by the activation-induced cytidine deaminase (AID). Upon germinal centre exit, B cells differentiate into antibody-secreting plasma cells. Germinal centre maintenance and terminal fate choice require transcriptional reprogramming that associates with a substantial reconfiguration of DNA methylation patterns. Here we examine the role of ten-eleven-translocation (TET) proteins, enzymes that facilitate DNA demethylation and promote a permissive chromatin state by oxidizing 5-methylcytosine, in antibody-mediated immunity. Using a conditional gene ablation strategy, we show that TET2 and TET3 guide the transition of germinal centre B cells to antibody-secreting plasma cells. Optimal AID expression requires TET function, and TET2 and TET3 double-deficient germinal centre B cells show defects in CSR. However, TET2/TET3 double-deficiency does not prevent the generation and selection of high-affinity germinal centre B cells. Rather, combined TET2 and TET3 loss-of-function in germinal centre B cells favours C-to-T and G-to-A transition mutagenesis, a finding that may be of significance for understanding the aetiology of B-cell lymphomas evolving in conditions of reduced TET function.
TL;DRCombined TET2 and TET3 loss‐of‐function in germinal centre B cells favours C‐to‐T and G‐ to‐A transition mutagenesis, a finding that may be of significance for understanding the aetiology of B‐cell lymphomas evolving in conditions of reduced TET function. (Semantic Scholar)

